Skeletal Metastasis

1 - I can do better 2 - Jury's out 3 - Pretty darn good 4 - Splendiferous 5 - Awesometastic by 2 people | Log in to rate

Ranked #1,187 in Health, #21,158 overall

Skeletal Metastasis

 

 

 

         

Cancer affecting the skeleton is more often metastatic than primary

The skeleton is the 3rd most common  site for metastases

The axial skeleton is involved in 70% of cases ( Batson's Valveless

Vertebral Vein System )

The commonest cause of bone metastases to the hand is lung cancer

 

Common Primary Tumours In Adults: 

Adenocarcinomas of :

1. Breast

2. Prostate

3. Lung

4. Kidney

5. Thyroid

Common Primary Tumours in Children 

Children:

1. Neuroblastoma

2. Wilm's Tumour

3. Rhabdomyosarcoma

4. Retinoblastoma

Differential Diagnosis 

Destructive Bone Lesion In An Adult Patient :

1. Metastases

2. Multiple Myeloma (Picture)

3. Lymphoma

Lymphoma 

Note the calcified para-aortic nodes.

Destructive Bone Lesions in A Child < 10 Years : 

Multiple Lesions :

1 ) Osteomyelitis

2 ) Eosinophilic Granuloma

3 ) Vascular Lesions

4 ) Metastases: Neuroblastoma, Wilm's Tumour

CLINICAL PRESENTATIONS : 

Patients can present in a variety of ways

It can mimic other pathologic entities and is hard to recognize.

It posts as a challenge to the treating orthopaedic surgeon, especially when patient present with a pathological fracture

PAIN : 

Lesions may be extremely painful to asymptomatic

Most patient present with pain that is unresponsive to anti-inflammatory medications and narcotics.

2 types of pain :

Cancer pain : related to nociceptive stimuli

eg. Tissue stretching, tumour haemorrhage/necrosis,
compression of local structures, local irritation

- usually responds to any medical intervention that decreases the tumour burden or growth

eg. Chemotherapy, Radiotherapy etc

2. Functional/Mechanical pain : resulting from impending pathological fracture.

Neurological Complaints : 

Spinal metastases with associated nerve root or cord compression

Pelvic metastases - leg pain mimics sciatica

Disruption Of Heamatopoiesis : 

Anemia ( Normochromic-normocytic )

HYPERCALCAEMIA : 

Common with certain tumours :

1. Myeloma

2. Lymphoma

3. Lung

4. Breast

Early Symptoms :

- Polyuria, polydipsia

- Aneroxia

- Easy Fatigability

- Weakness

Late Symptoms :

- Apathy, irritability, depression

- Coma

- Profound muscle weakness

- Nausea, vomiting, abdominal pain

- Pruritus

Radiographs 

Good quality biplanar ( AP-Lateral ) films that include the involved bone and one joint proximal and distal.

Pelvis :

AP view

Obturator Oblique View : anterior pelvic column & posterior wall of acetabulum

Iliac Oblique View : posterior pelvic column & anterior wall of acetabulum

A significant amount of bone must be destroyed before a lesion will appear lytic on X-ray film

Classification of radiological appearance :

1. Lytic (Renal Ca, Thyroid Ca, Breast Ca, Lung Ca, Head and Neck & CNS Malignancies )

2. Blastic ( Prostate Ca )

3. Mixed ( Breast Ca, Gastrointestinal Ca )

Breast Cancer (Blastic) 

Metastasis from breast cancer can be blastic or lytic.

Shown here is the blastic type.

Breast Ca (Lytic ) 

Lytic type of breast ca metastasis.

Prostate Cancer 

Metastasis from prostate cancer is typically blastic.

Kidney Cancer 

Renal cell carcinoma typically give rise to lytic and expansile lesion due to the high vascularity.

Magnetic Resonance Imaging : 

Imaging modality of choice for suspected bone metastases in the extremities and pelvis

Provide images in multiple planes

Define the extent of soft tissue and intraosseous tumour extension & critical neurovascular structures

Very sensitive to early marrow replacement

Contrast-enhanced MRI : useful in monitoring tumour
response to chemotherapy

CT SCAN : 

Assessment of bone anatomy and cortical destruction

Gold standard in assessing the amount and quality of bone remaining

Affects surgical treatment decisions and reconstruction options

-- esp in pelvic & acetabular lesions

NUCLEAR MEDICINE IMAGING : 

99mTc or 201 Tl ( Thallium-201-chloride )

Search for other skeletal sites of tumour involvement

Evaluate chemotherapeutic response of tumour

Virtually always +ve in metastatic bone disease

except :

-- Multiple Myeloma
-- Rapid and severe destructive lesion (lung, kidney)
-- Melanoma

ARTERIOGRAPHY : 

Largely replaced by MRI and MRA

Useful when vascular involvement of the tumour is suspected & in metastatic lesions where preoperative embolisation is considered

POSITRON EMISSION TOMOGRAPHY : 

An important adjunct to CT scan and MRI

Highly sensitive

Provides complementary metabolic information

Commonest radiotracer used :

Flourine-18-flourodeoxyglucose ( 18F-FDG )

- accumulates in area of high glycolysis and membrane transport of glucose

- both increased in malignant tissue, demonstrating tumour response to neoadjuvant chemotherapy

- detect bone metastases

- differentiating recurrent disease from scar

SKELETAL RESPONSES TO METASTATIC DISEASE 

Metasatases are most often destructive and osteolytic than osteoblastic

Substances secreted by tumour cells activate both osteoblasts and osteoclasts

In most tumours, osteoclastic activation predominates

Osteoblastic lesions 

Less common

In adults : Prostate & Breast Ca

In children: Medulloblastoma,Lymphoma,Retinoblastoma

Osteoblastic response could be so pronounced that it obscures the underlying neoplasm

Diagnosis : 

Biopsy & Histopathological Examination

After a thorough history and examination, blood tests and radiological investigations, 85% of the primary tumours that present initially with an osseous metastases can be identified.

Subsequent treatment depends on the type of tumour.

In patients in whom no primary tumour is detected, results of chemotherapy is disappointing and may not be indicated.

MANAGEMENT 

3 Main Goals:

1. Functional Preservation & Restoration

2. Pain Relief

3. Quality Of Life Extension

GOAL OF SURGERY 

Whether for an impending or pathological fracture, the goal are :

1. Reinforce or replace the compromised bone with rigid and durable construct.

2. Provide functional stability and pain relief.

PRINCIPLES OF SURGICAL MANAGEMENT : 

1. Understand the patient's prognosis

2. Provide adequate perioperative antibiotic coverage and optimize patient's medical condition before surgery

3 Verify histology in lesions that present as the first skeletal metastases

4 Actual management of pathological fracture is secondary and proceeds only after all necessary diagnostic tests are completed

5. In patients with previous radiation fields, ensure adequate soft tissue coverage and carefully avoid unnecessary trauma to soft tissue flaps

6. Remove as much of the lesion as possible without negatively affecting the ability to provide proper fixation

7. Intralesional margins are acceptable because the intent of surgery is to mechanically reinforce rather than to surgically cure

8. Use internal fixation ± bone cement or cemented prosthetic replacements as indicated to create a stable, durable construct and to fulfill the goal of immediate return to function. Fixation in this setting must persist for the life of the patient

9. Use adjuvant therapy in the form of postoperative radiation therapy and/or chemotherapy when indicated

Prophylactic Internal Fixation 

Fidler (1973) assessed fracture rates based on radiological involvement :

If less than 50% diameter :
-- 2.3% incidence of fracture

If greater than 50% :
-- 60% go on to fracture

Fidler M : Prophylactic internal fixation of secondary neoplastic deposits in bone. Br Med J 1:341-343, 1973

Mirels Objective Scoring System 

Mirels H : Metastatic disease in long bones. A proposed scoring system for diagnosing pathological fractures. Clin Orthop 249:256-264, 1989

The scoring system depends on 4 parameters:

1. Pain (1=Mild, 2=Moderate, 3=Functional)

2. Diameter of lesion (1=<1/3, 2=1/3-2/3, 3=>2/3)

3. Type of lesion (1=Blastic, 2=Mixed, 3=Lytic)

4. Site (1=Upper Limb, 2=lower Limb, 3=Peritrochanteric)

Prophylactic Fixation is indicated if score >9

Factors to consider. 

1. Overall health of the patient + life expectancy

2. Expected response of the tumour and patient to adjuvant interventions like radiotherapy

3. Surgeon's experience and capability at bone reconstruction

4. The reconstructability of the affected bone

5. Extent of functional disruption that would occur if a fracture does occur ( eg. UL vs LL )

6. It is always easier and better to fix an impending pathological fracture than to heal one

RELATIVE CONTRAINDICATIONS TO SURGERY 

1. Moribund patient

2. Distorted mental status

3. Disorientated, agitated, flailing patient

4. Multiple risks :

a) Infections

b) Poor rehabilitation support

c) Fluid overload

5. Severely limited life expectancy- Insufficient time to heal and enjoy the benefits of restored or preserved functions

7. Unrestorable function : Disease too extensive- no good reconstruction is possible

8. Venous thromboembolic disease of the lower limb

Criteria For Internal Fixation 

1. > 50% cortical bone destruction

2. High Stress Site :

a) Subtrochanteric region

b) Femoral Diaphysis

c) Humeral Diaphysis

d) Humeral anatomic neck

3. Purely lytic lesion

4. Weight bearing pain

5. Pain following irradiation

SURGICAL OPTIONS : 

1. Internal Fixation

2. Prosthetic Devices

Internal Fixation-Intramedullary Nail 

Usually statically locked

Cement augmentation as necessary

Used for diaphyseal lesion

Internal Fixation-Plating 

Supplement with cement

Used as buttress plate

Used for metaphyseal lesion

Curette the tumour while conserving cortical bone

PROSTHETIC DEVICES 

Indications:

1. Femoral Neck Fractures

2. Large destructive proximal femoral lesions (picture)

3. Large destructive lesions of proximal humerus

Endoprosthesis 

The destructed proximal femur was resected and reconstructed with long stem endoprosthesis.

Conservative management 

Indicated when the goals of pain relief and functional preservation or restoration are unattainable or unreasonable with surgical management or when these goals can be met satisfactorily with medical management alone

eg. A metastatic lesion detected during a screening study but clinically asymptomatic & has no risk of fracture.

Regular follow-up keeping an eye for progression of lesion or clinical symptoms (eg pain, impending fracture)

Generally includes :

- Radiotherapy

- Chemotherapy

- Hormonal therapy

Ca Breast : Anti-estrogen

Ca Prostate : Antiandrogens & LHRH Agonists

- Pain management

- Metabolic or pharmacologic manipulations (Biphosphonates)

- Nutrition

- Psychological support

Radiotherapy : 

Overall 85% response rate

Complete pain relief in 50%, partial pain relief in 35%

More than half respond within 1-2 weeks

Median duration of pain relief 12-15 weeks

Tumor necrosis followed by collagen proliferation, woven bone formation, and replacement with lamellar bone

Recalcification by 2-3 months

Various dose and fractionization schedules

Biphosphonates 

Inhibit bone resorption by :

1. Interaction with molecules on the osteoclast surface

2. Prevention of osteoclast attachment to the bone matrix

3. Incorporation of the drug into the inorganic bone matrix itself

4. Forms an analog to calcium hydroxyapatite that is more resistant to osteoclast degradation than the native matrix

PROGNOSIS 

Coleman RE : Skeletal complications of malignancy. Cancer 80-1588, 1997

Median Survival in months:
(Percentage of 5 year survival in bracket)

Thyroid - 48 (40)

Prostate -40 (25)

Breast - 24 (20)

Myeloma - 20 (10)

Kidney - 6 (10)

Lung - <6 (<5)

Melanoma - <6 (<5)

Link List for Bone Metastasis 

Skeletal Metastasis AAOS
Learn more about skeletal metastasis at AAOS
Mechanism of tumour metastasis
Molecular mechanism of tumour metastasis to bone. A 'must read' by MMED candidates.
Ebook on skeletal metastasis
Treatment of metastatic bone disease by Martin Malawer.
Metastatic carcinoma of long bone
Journal article on metastatic carcinoma of long bone.
Metastatic Melanoma
Bone metastasis from malignant melanoma
Management of bone metastasis
Management of Bone Metastases in Advanced Breast Cancer

New Featured Lenses 

New Featured Lenses 

Great Stuff on Amazon 

Multifocal skeletal tuberculosis.(Case Report): An article from: Southern Medical Journal

Amazon Price: $5.95 (as of 12/22/2009) Buy Now

Skeletal Metastases

Amazon Price: $125.00 (as of 12/22/2009) Buy Now

Bone and Cancer (Topics in Bone Biology)

Amazon Price: $309.00 (as of 12/22/2009) Buy Now

New Amazon Plexo 

Reader Feedback 

submit

by KMLIAU

Lecturer, Universiti Sains Malaysia. (more)

Explore related pages

Create a Lens!